Receive personalised medical treatment at your bedside
Imagine a world where disease outbreaks could be stopped at the source, a world where patients could receive personalised treatment for specific diseases and have it manufactured at their bedside. The Centre for Process Innovation (CPI) is working towards making this concept a reality by helping companies to scale down traditional biopharmaceutical manufacturing methods and develop new techniques for the future delivery of precision medicine.
The global healthcare and life sciences sector is in the midst of change which presents both opportunities and challenges to patients, hospitals and business alike. This change is being driven by supply and demand pressures, lifestyle choices, longevity and a rise in the incidence of chronic disease.
The current worldwide population is over 7bn and is rising exponentially. By 2050, it is estimated that one in five of the population will be over 60, bringing a rise in the frequency of age related disorders such as cancer, cardiovascular disease and neurological disorders. Furthermore, since 1980 there has been a global rise in human infectious disease outbreaks, the recent Ebola epidemic demonstrated the reality of this. These statistics identify not only a demand for change, but an opportunity to develop new ways in which therapies are developed, manufactured, transported and administered.
Featured products
MAX17793
Analog Devices Inc.
3V to 80V, 3A, High-Efficiency, Synchronous Step-Down DC-DC Converter
| SKU: | MAX17793 |
|---|---|
| Stock: | 9316 |
| Cost: | $3.64 |
MAX22516
Analog Devices Inc.
IO-Link Data Link Controller with Transceiver and Integrated DC-DC
| SKU: | MAX22516 |
|---|---|
| Stock: | 8000 |
| Cost: | $5.42 |
